BASF makes takeover approach for chemicals rival Evonik
Evonik continues to oppose a takeover approach from BASF, maintaining its resistance despite ongoing contact between the chemical companies. Evonik previously declined an offer of EUR 24 per share, valued at approximately EUR 11.2 billion or $12.5 billion, and rejected a second bid due to strong cash flow and divestment plans. Meanwhile, Evonik reported third-quarter adjusted EBITDA rose 40% to EUR 629 million, a financial performance that analysts have rewarded. BASF continues to pursue the transaction despite facing rejection from the target company's board.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ Evonik declined a takeover bid from BASF valued at EUR 24 per share, equivalent to approximately EUR 11.2 billion or $12.5 billion.
- ✓ Evonik's board officially rejected BASF's second and improved takeover offer, citing strong cash flow and divestment plans.
- ✓ Evonik declined takeover negotiations with BASF on 30 October.
- ✓ Evonik Q3 adjusted EBITDA rose 40% to EUR 629 million.
What changed
Evonik remains opposed to the takeover offer after meeting with BASF, according to a source familiar with the matter.
Live updates
-
Evonik Remains Opposed to BASF Takeover Bid
Evonik continues to oppose a takeover approach from BASF, maintaining its resistance despite ongoing contact between the chemical companies. Evonik previously declined an offer of EUR 24 per share, valued at approximately EUR 11.2 billion or $12.5 billion, and rejected a second bid due to strong cash flow and divestment plans. Meanwhile, Evonik reported third-quarter adjusted EBITDA rose 40% to EUR 629 million, a financial performance that analysts have rewarded. BASF continues to pursue the transaction despite facing rejection from the target company's board.
Why it matters
The proposed chemical mega-merger involves two major German industry players based in Essen and Ludwigshafen. Evonik previously drew a line at formal takeover negotiations on 30 October while agreeing to hold confidential exchanges. Analysts are closely watching how Evonik's financial health and strategic options will influence the outcome of the pursuit.
What is confirmed
- Evonik declined a takeover bid from BASF valued at EUR 24 per share, equivalent to approximately EUR 11.2 billion or $12.5 billion.
- Evonik's board officially rejected BASF's second and improved takeover offer, citing strong cash flow and divestment plans.
- Evonik declined takeover negotiations with BASF on 30 October.
- Evonik Q3 adjusted EBITDA rose 40% to EUR 629 million.
Still unconfirmed
- Evonik is preparing a rival strategy while facing BASF's takeover bid.
- Evonik remains opposed to the takeover offer after meeting BASF, as indicated by a source familiar with the matter.
What to watch next
- Any formal update on whether confidential exchanges between Evonik and BASF will continue or terminate permanently.
- Further developments regarding Evonik's rival strategy and standalone divestment plans.
- Potential adjustments to BASF's takeover bid valuation or structure.
confidence 90%Sources used for this update (3)
- www.marketscreener.com — Evonik remains opposed to takeover offer after meeting BASF ...
- wwconemedia.com — BASF's $12.3-Billion Takeover Bid Faces New Twist as Evonik ...
- www.ad-hoc-news.de — Evonik Draws a Line at Talks With BASF While Analysts Reward ...
-
Evonik rejects BASF's $12.5 billion takeover offer
Evonik Industries has declined a takeover bid from BASF, with the offer of EUR 24 per share, equivalent to approximately EUR 11.2 billion or $12.5 billion, being deemed too low. Despite the rejection, BASF continues to pursue the transaction. Evonik's board officially rejected BASF's second and improved takeover offer, citing strong cash flow and divestment plans.
Why it matters
The attempted takeover is a significant development in the German chemical industry, with BASF seeking to enhance its position through consolidation. Evonik's rejection reflects its intention to remain independent. The outcome will have implications for the industry and the companies' future strategies.
What is confirmed
- Evonik Industries rejected a takeover approach from BASF.
- BASF offered EUR 24 per share for Evonik.
- The rejected offer was equivalent to approximately EUR 11.2 billion.
- Evonik reported EUR 369M Q3 free cash flow.
- Evonik's nine-month total free cash flow was EUR 601M.
Still unconfirmed
- BASF is backed by stronger third-quarter earnings and an improved balance sheet.
What to watch next
- RAG Foundation's decision on the takeover
- Union demands and negotiations
- BASF and Evonik's future production investments
confidence 90%Sources used for this update (6)
- www.ad-hoc-news.de — Evonik Pushes Back on BASF Approach as Cash Flow and ...
- www.crediblenews.com — Evonik Refuses BASF’s $12.5 Billion Takeover Offer
- www.ad-hoc-news.de — Evonik Rejects BASF Talks Outright as Kamieth Sets 2028 Horizon
- chemdive.com — BASF, Evonik Declares Separate Production Investments
- www.coatings-tech.com — Specialty Chemicals: Evonik Rejects BASF Takeover Bid
- www.aktien.news — Übernahmeschlacht in der Chemiebranche: Evonik weist BASF ...
-
Evonik Rejects BASF Takeover Approach
Chemicals producer Evonik Industries rejected a takeover approach from rival BASF after a raised offer exceeding eleven billion euros was deemed too low. Despite the rejection from the specialty chemicals maker, BASF continues to pursue the transaction, backed by stronger third-quarter earnings and an improved balance sheet. BASF Chief Executive Officer Markus Kamieth frames the consolidation as a domestic response, offering job and location guarantees in Germany. Negotiations face critical hurdles, including final pricing, union demands, and the ultimate decision by the RAG Foundation.
Why it matters
Consolidation within the German chemical sector reflects broader economic pressures on domestic manufacturing. BASF is attempting to use its stronger financial footing to absorb a major competitor, while managing complex labor and ownership structures in Germany. The primary obstacles center on valuation disagreements, workforce protection demands, and the position of the RAG Foundation.
What is confirmed
- Evonik Industries rejected a takeover approach from rival BASF.
- A raised offer exceeding eleven billion euros was deemed too low.
- BASF continues to pursue the transaction, supported by stronger third-quarter earnings and an improved balance sheet.
- BASF Chief Executive Officer Markus Kamieth pitches the consolidation as a domestic response, offering job and location guarantees in Germany.
Still unconfirmed
- Negotiations involve critical hurdles including final pricing, union demands, and the ultimate decision by the RAG Foundation.
What to watch next
- A decision or revised proposal by the RAG Foundation regarding the takeover approach.
- Further statements from Evonik Industries or BASF regarding pricing and union negotiations.
confidence 90%Sources used for this update (4)
- www.law360.com — Mergers & Acquisitions : Law360 UK : Legal News & Analysis
- www.marketscreener.com — Global Stocks Fall on Higher Oil Prices, AI Pullback | MarketScreener
- www.marketbeat.com — Top Biotech Stocks To Research - October 14th | MarketBeat
- www.evonik.com — Ad-hoc: Statement by the Executive Board of Evonik Industries ...
-
Evonik Rebuffs BASF Takeover Approach as Talks Continue
Chemicals producer Evonik Industries rejected a takeover approach from rival BASF, with reports indicating a raised offer exceeding eleven billion euros was deemed too low. Despite the rejection by the specialty chemicals maker, BASF continues to pursue the transaction, supported by stronger third-quarter earnings and an improved balance sheet. BASF Chief Executive Officer Markus Kamieth pitches the consolidation as a domestic response, offering job and location guarantees in Germany. Negotiations involve critical hurdles including the final pricing, union demands, and the ultimate decision by the RAG Foundation.
Why it matters
A potential merger between two of Germany largest chemicals groups would significantly reshape the global specialty materials sector. BASF leverages robust financial results to pursue further acquisitions while attempting to secure domestic backing. The negotiations sit at a critical stage involving multiple corporate and stakeholder interests.
What is confirmed
- Evonik Industries rebuffed a takeover approach from rival BASF.
- BASF is pursuing further acquisitions supported by stronger third-quarter earnings and an improved balance sheet.
- BASF CEO Markus Kamieth is pitching the acquisition with job and location guarantees within Germany.
Still unconfirmed
- Evonik is expected to publish a statement rejecting a raised takeover offer worth eleven billion euros as too low.
What to watch next
- Evonik publishing an official statement regarding the rejected takeover offer
- Any formal response or revised bid from BASF CEO Markus Kamieth
- The final decision by the RAG Foundation on how to proceed with the negotiations
confidence 90%Sources used for this update (4)
- www.marketscreener.com — Evonik Industries Rebuffs BASF's Takeover Approach
- cen.acs.org — BASF pushes Evonik deal as results sparkle
- www.globalcosmeticsnews.com — BASF Pursues Further Acquisitions as Evonik Takeover Talks ...
- www.marketscreener.com — 'FT': Evonik to Reject Raised BASF Offer
-
BASF Pushes Evonik Takeover as Talks Reach Critical Stage
Chemical giant BASF faces three primary hurdles in its pursuit of rival Evonik, as negotiations reach a make-or-break stage over an 11.2 billion euro bid. BASF CEO Markus Kamieth is pitching the acquisition as a strong German response, offering far-reaching job and location guarantees within the country. The potential consolidation of the two German chemicals groups could redraw the global specialty materials map. Key obstacles remaining in the active talks include the acquisition price, union demands, and the final decision by the RAG Foundation regarding how to proceed.
Why it matters
The proposed acquisition brings together two major German chemical entities, signaling a potential wave of consolidation within the specialty materials sector. Previous discussions left the merger status undecided before BASF adjusted its proposal to roughly 24 euros per share. The RAG Foundation holds ultimate authority over the transaction's trajectory, while labor representatives scrutinize the impact on domestic facilities.
What is confirmed
- BASF is pursuing a takeover of rival Evonik with a bid valued at roughly 24 euros per share, totaling well over 11 billion euros.
- BASF CEO Markus Kamieth is pitching the acquisition as a strong German response with far-reaching job and location guarantees.
Still unconfirmed
- The takeover talks have hit a make-or-break stage facing hurdles regarding price, the RAG Foundation, and unions.
What to watch next
- Decisions by the RAG Foundation on whether to advance the consolidation.
- Official responses from union representatives regarding the proposed job and production base guarantees.
- Further announcements from BASF CEO Markus Kamieth concerning the merger terms.
confidence 90%Sources used for this update (3)
- seekingalpha.com — Patient Capital Management Q3 2026 Commentary
- www.bloominglobal.com — BASF–Evonik Takeover Talks Hit the Make-or-Break Stage: Could ...
- www.europesays.com — BASF CEO pitches Evonik takeover: “Strong German response”
-
BASF Raises Takeover Bid for Evonik Above 11 Billion Euros
Chemical giant BASF has increased its takeover offer for rival Evonik to roughly 24 euros per share, pushing the total valuation to well over 11 billion euros. The renewed acquisition effort includes job and production base guarantees within Germany. Talks regarding the potential consolidation of the two German chemicals groups remain active, with the RAG Foundation holding the decision on how to proceed. Insiders indicate that BASF adjusted its proposal following earlier discussions that left the merger status undecided.
Why it matters
The potential transaction carries significant economic and political weight for the European chemical sector. BASF previously maintained its acquisition interest while offering initial employment and site commitments in Germany. The RAG Foundation serves as Evonik's largest shareholder and continues to weigh the next moves as negotiations develop.
What is confirmed
- BASF has raised its takeover offer for Evonik to roughly 24 euros per share, valuing the deal above 11 billion euros.
- The offer includes job and production site commitments in Germany.
- The RAG Foundation is Evonik's largest shareholder.
- BASF confirmed on September 25, 2026, that it held soundings with the RAG Foundation and Evonik regarding a potential takeover.
Still unconfirmed
- Insiders suggest that BASF may revise its approach further if negotiations continue to evolve.
What to watch next
- Decisions by the RAG Foundation regarding the revised offer
- Further announcements from BASF or Evonik on the merger talks
confidence 95%Sources used for this update (6)
- www.basf.com — Careers - BASF
- www.basf.com — Products - BASF
- www.marketscreener.com — Movement in takeover battle, BASF apparently raises offer for Evonik
- www.briefs.co — BASF sweetens Evonik bid to above €11 billion
- www.basf.com — Latest information on a possible combination of BASF and Evonik
- finance.yahoo.com — Germany's BASF intensifies its pursuit of Evonik - Yahoo Finance
-
BASF Leaves Door Open for Evonik Takeover With Concessions
Chemical giant BASF maintains interest in acquiring rival Evonik, offering employment and production base guarantees in Germany if the deal is completed. Evonik shares closed at 21.46 euros, rising 2.4 percent. The RAG Foundation, Evonik's largest shareholder, leaves the next move on a BASF offer to the two companies as merger talks remain undecided. Insiders suggest BASF may revise its approach, while the potential transaction carries significant economic and political implications for the European chemical sector.
Why it matters
Consolidation pressures from Chinese competitors drive the ongoing takeover interest within the European chemical industry. Major stakeholders, including political blocks and the RAG Foundation, face intense resistance from unions regarding potential job losses. Reviewing the specialty chemicals maker's books remains a prerequisite for any sweetened proposal following an earlier rejected 10.3 billion euro offer.
What is confirmed
- BASF has stated that it will maintain existing employment and production base guarantee clauses for Evonik in Germany if it completes the acquisition.
- Evonik closed at 21.46 euros, up 2.4 percent.
- The RAG Foundation left the next move on a BASF offer to the two companies.
Still unconfirmed
- BASF may revise its takeover approach for Evonik.
What to watch next
- Decisions by the boards of BASF and Evonik regarding merger talks
- Actions by the RAG Foundation on the BASF offer
confidence 95%Sources used for this update (4)
- www.europesays.com — BASF and Evonik: Merger talks remain undecided - Germany
- news.chemnet.com — BASF makes major concessions: plans to commit that it will ...
- www.ad-hoc-news.de — Evonik's Boardroom Holds the Key as BASF Circles and the ...
- www.european-coatings.com — BASF and Evonik: Merger talks remain undecided - European ...
-
BASF Weighs Higher Evonik Bid Amid Job Pledges
Chemical giant BASF considers raising its rejected €10.3 billion takeover offer for rival Evonik after pressure from Chinese competitors. To ease intense political and union resistance, Ludwigshafen-based BASF is prepared to offer binding job and site guarantees. However, a person familiar with the transaction noted that any sweetened proposal depends on reviewing the specialty chemicals maker's books first. Evonik shares currently sit near 52-week highs while the major shareholder, the RAG Foundation, and political blocks weigh the ongoing consolidation pressures facing the European chemical sector.
Why it matters
The potential transaction reflects severe regional market stress driven by high energy costs, weak industrial demand, and intense competition from Chinese manufacturers. Political friction is mounting as North Rhine-Westphalia politicians push back and the SPD proposes a state stake to protect Evonik's independence. Meanwhile, the RAG Foundation holds a significant gatekeeper position with its stake in Evonik.
What is confirmed
- BASF previously submitted an initial takeover offer of €10.3 billion for Evonik, which was rejected as too low.
- The initial offer of €22.15 per share valued Evonik, including debt, at more than €14 billion.
- BASF is offering job and site guarantees to address union and political concerns regarding the takeover.
- The RAG Foundation is Evonik's largest shareholder with a stake of 43 to 44 percent.
Still unconfirmed
- BASF is prepared to discuss a higher offer only after conducting due diligence on the specialty chemicals group.
What to watch next
- Board of trustees meeting held by the RAG Foundation
- Supervisory board meeting held by BASF
- Any official response from Evonik regarding access to corporate books or a revised bid
confidence 95%Sources used for this update (10)
- www.marketscreener.com — Insider: BASF would not tamper with job guarantees in Evonik takeover
- www.rte.ie — BASF considers raising offer for Evonik, sources say - RTÉ
- breakthroughgroup.com — Evonik Takeover Drama: Political Block Puts BASF Bid at Risk
- www.marketscreener.com — Possible Moves on BASF's Takeover of Evonik Before the ...
- www.newscase.com — BASF Dangles Job and Site Pledges as Evonik's 44% Gatekeeper ...
- www.marketscreener.com — Sources: BASF Open to Higher Bid for Evonik
- chemicals.economictimes.indiatimes.com — BASF’s speciality chemicals push gathers pace as Evonik deal ...
- dailydigestinvest.com — BASF offers job and site guarantees to revive Evonik takeover ...
- www.chemorbis.com — BASF reportedly willing to offer job guarantees in Evonik ...
- www.ad-hoc-news.de — Evonik’s takeover puzzle widens as BASF weighs a richer bid
-
BASF Expected to Raise Takeover Bid for Evonik
Chemical giant BASF plans to continue its pursuit of rival Evonik after its initial €10.3 billion takeover offer was rejected for being too low. Although no active negotiations are currently underway following the rebuffed opening approach, insiders indicate that the current proposal is not the final word and a higher offer could emerge. The potential transaction highlights ongoing regional market consolidation driven by high energy costs, weak industrial demand, and intense competition from Chinese manufacturers.
Why it matters
European chemical producers face severe economic headwinds from expensive energy and Chinese market pressure, prompting consolidation. A combined entity would merge BASF's massive scale and integration with Evonik's specialized technology platforms, including its standing as a major supplier of coatings crosslinkers, curing agents, and hydrogen peroxide. Meanwhile, Germany's RAG Foundation acts as the cornerstone asset holder for Evonik.
What is confirmed
- BASF has approached rival Evonik regarding a potential takeover.
- An initial takeover bid valued at €10.3 billion was rejected for being too low.
- No active negotiations are currently underway between the two chemical companies.
Still unconfirmed
- Germany's RAG Foundation dropped its Evonik veto floor.
What to watch next
- Whether BASF submits a revised, higher takeover offer for Evonik.
- Any resumption of formal negotiations between BASF and Evonik.
confidence 90%Sources used for this update (6)
- www.marketscreener.com — Insider: BASF offer for Evonik "not the last word"
- alliancechemical.com — BASF, Evonik and Hydrogen Peroxide: What the 2019 FTC Case Shows
- klinegroup.com — What A BASF–Evonik Merger Could Mean For Specialty Chemicals
- polyureamagazine.com — BASF Confirms Exploratory Talks on Potential Evonik Takeover
- www.europesays.com — Germany Coal Fund Drops Evonik Veto Floor, Opening Path to ...
- www.globalbankingandfinance.com — BASF could make higher offer for Evonik, sources say
-
BASF Considers Revised Evonik Bid Following Rejection
Chemical maker BASF is evaluating a second takeover proposal for rival Evonik after its initial bid valued at €10.3 billion was rejected for being too low. While the opening approach was rebuffed and no active negotiations are currently underway, discussions have previously taken place following exploratory talks confirmed on September 25, 2026. The potential transaction emerges as European chemical producers grapple with weak industrial demand, high energy costs, and stiff competition from Chinese manufacturers, driving regional market consolidation.
Why it matters
European chemical producers face severe economic headwinds that force companies to seek consolidation to survive. Evonik is already pursuing its own restructuring plan involving 3,200 job cuts. A successful acquisition by BASF introduces further labor uncertainty as worker representatives warn that up to 4,000 additional jobs could be at risk.
What is confirmed
- Evonik has rejected a takeover offer from BASF that valued the company at €10.3 billion.
- BASF confirmed exploratory talks regarding Evonik on September 25, 2026.
- Evonik is pursuing an internal restructuring plan to cut 3,200 jobs.
Still unconfirmed
- BASF is still working on an Evonik takeover and is weighing a second bid, though no talks are currently underway according to Handelsblatt.
- Labor representatives fear that up to 4,000 Evonik jobs are at risk if a BASF takeover succeeds.
What to watch next
- Whether BASF submits a formal second takeover bid with a higher valuation
- Any official confirmation of renewed negotiations between BASF and Evonik
- Further statements from labor representatives regarding potential job cuts
confidence 90%Sources used for this update (2)
- breakthroughgroup.com — Evonik Faces BASF Bid Amid Deep Job Cuts, Sharp Splits
- www.ad-hoc-news.de — Evonik's Takeover Poker: BASF Weighs a Second Bid as a 54% ...
-
Evonik Rejects BASF Takeover Bid as Talks Continue
Evonik has rejected a takeover offer from rival chemical maker BASF, according to multiple industry reports. The initial proposal valued the company at €10.3 billion, an amount the German specialty chemicals producer deemed too low. Despite the rejection, discussions between the two companies are continuing. The approach follows exploratory talks confirmed by BASF SE on September 25, 2026. European chemical producers face mounting pressure from weak industrial demand, high energy costs, and intense competition from Chinese manufacturers, driving regional consolidation efforts.
Why it matters
The RAG Foundation confirmed it can sell its entire 44 percent stake in Evonik. This decision removes a blocking minority that previously prevented a takeover, opening the door for potential consolidation in Europe's chemicals sector.
What is confirmed
- Evonik rejected a takeover bid by chemical maker BASF.
- The Financial Times reported that the takeover offer was valued at €10.3 billion.
Still unconfirmed
- The €10.3 billion offer was valued at $11.7 billion.
What to watch next
- Whether BASF will raise its takeover offer above the rejected €10.3 billion valuation.
- Further updates on the continuation of talks between Evonik and BASF.
- Any announcements from the RAG Foundation regarding the sale of its 44 percent stake in Evonik.
confidence 100%Sources used for this update (3)
- chemicals.economictimes.indiatimes.com — BASF’s Evonik overture signals a wider chemicals shake-up in ...
- ecoplasticsinpackaging.com — Chemicals maker Evonik rejects €10.3bn BASF takeover offer
- www.bicmagazine.com — Evonik Rejects BASF's Takeover Bid — Talks Continue - BIC ...
-
RAG Foundation Drops Veto Floor, Clearing Path for BASF-Evonik Deal
Germany's RAG Foundation confirmed it can sell its entire 44 percent stake in Evonik, removing a blocking minority that previously prevented a takeover. The announcement follows BASF SE confirming exploratory talks on September 25, 2026, regarding a potential acquisition of Evonik Industries AG. Evonik rejected an initial proposal, which press reports valued at €10.3 billion, deeming the offer too low. European chemical producers are pursuing consolidation to combat weak industrial demand, high energy costs, and intense competition from Chinese manufacturers.
Why it matters
The European chemical sector faces severe pressure from high energy expenses and growing Asian market competition. Combining BASF's large-scale chemical operations with Evonik's specialty additives and high-performance materials aims to achieve strategic operational savings. The transaction would heavily impact global supply chains, including beauty ingredient and feed ingredient markets.
What is confirmed
- Germany's RAG Foundation confirmed it could sell its entire 44% Evonik stake.
- BASF confirmed exploratory discussions regarding a potential takeover of Evonik Industries AG with Evonik management and RAG-Stiftung.
- European chemical producers face weak demand, high costs, and growing competition from China.
Still unconfirmed
- BASF made an initial takeover proposal valued at €10.3 billion which Evonik rejected.
What to watch next
- Whether BASF submits a higher takeover bid following the removal of the RAG Foundation veto floor
- Formal responses from Evonik management regarding future acquisition terms
confidence 90%Sources used for this update (6)
- www.techtimes.com — Germany Coal Fund Drops Evonik Veto Floor, Opening Path to BASF Takeover - Tech Times
- www.personalcareinsights.com — BASF confirms Evonik takeover talks as initial offer ...
- chemicalmarketanalytics.com — BASF & Evonik: Global Capacity Analysis
- www.lubesngreases.com — Evonik Rebuffs BASF Takeover - Lubes'N'Greases
- www.lokchem.com — BASF Explores Evonik Deal as Global Chemical Industry Faces ...
- www.feedbusinessmea.com — BASF explores Evonik deal with feed ingredients in focus
-
BASF Proposes Evonik Takeover to Consolidate European Chemicals
BASF has made a nonbinding takeover approach to German rival Evonik Industries in an effort to consolidate the struggling European chemicals sector. BASF contacted Evonik management and primary shareholder RAG-Stiftung regarding a transaction targeting a group valued at roughly €12 billion. Evonik confirmed receiving the proposal following media reports but rejected the initial offer after deeming it too low. The target company operates as a specialty chemicals maker, while the potential acquirer is recognized as the largest chemicals group globally by revenue, operating 234 production sites across 93 countries.
Why it matters
The proposed transaction reflects ongoing consolidation pressures within the European chemical industry. BASF operates through segments including chemicals, materials, industrial solutions, surface technologies, nutrition and care, and agricultural solutions. The company traces its origins to the Badische Anilin- & Soda-Fabrik founded in Mannheim in 1865 before establishing its headquarters in Ludwigshafen am Rhein.
What is confirmed
- BASF SE is a publicly traded German chemical corporation headquartered in Ludwigshafen am Rhein.
- BASF is represented in 93 countries and operates 234 production sites.
- BASF is the largest chemical corporation worldwide by revenue.
- BASF operates through the segments Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition and Care, and Agricultural Solutions.
- BASF approached Evonik Industries with a nonbinding takeover proposal.
- Evonik confirmed receiving the nonbinding approach from its larger peer in response to media reports.
Still unconfirmed
- Evonik rejected the initial offer after deeming it too low according to people familiar with the matter.
- The proposed transaction targets a group valued at roughly €12 billion.
What to watch next
- Whether BASF will revise its takeover offer to meet Evonik valuation expectations
- Any official statement from primary shareholder RAG-Stiftung regarding the consolidation approach
confidence 90%Sources used for this update (2)
- de.wikipedia.org — BASF – Wikipedia
- www.forbes.com — BASF | Company Overview & News - Forbes
-
BASF Proposes Takeover of German Chemical Rival Evonik
Chemicals giant BASF has approached German rival Evonik Industries with a nonbinding takeover proposal. BASF reached out to Evonik management and its primary shareholder, the RAG-Stiftung foundation, aiming to consolidate the struggling European chemicals sector. Evonik confirmed receiving the nonbinding approach from its larger peer in response to media reports, though specialty chemicals maker Evonik rejected the initial offer after deeming it too low according to people familiar with the matter. The proposed transaction targets a group valued at roughly €12 billion.
Why it matters
A combination between BASF and Evonik would represent a significant step toward consolidating Europe's fragmented chemicals industry. The approach highlights how major European industrial players are weighing structural changes to combat a difficult operational environment. However, labor representatives like the IG BCE trade union have raised concerns, noting that a takeover leaves many unanswered questions for employees.
What is confirmed
- BASF submitted a takeover proposal to German rival Evonik Industries.
- BASF approached both Evonik management and its primary shareholder, the RAG-Stiftung foundation.
- Evonik confirmed it received a nonbinding takeover approach from BASF.
- BASF entered initial talks over a takeover of smaller peer Evonik.
Still unconfirmed
- Evonik has rejected the takeover offer from BASF because the bid was deemed too low.
- The takeover targets a group valued at €12 billion.
What to watch next
- Whether BASF will return with a higher bid for Evonik
- Formal statements from the RAG-Stiftung foundation regarding the takeover approach
- Further responses from labor unions regarding potential employee impacts
confidence 100%Sources used for this update (19)
- Financial Times — BASF makes takeover approach for chemicals rival Evonik
- Bloomberg.com — BASF Made Merger Proposal to German Rival Evonik, Report Says
- Reuters — Germany's BASF approaches Evonik over potential takeover
- MarketWatch — Chemicals sector takeover bid launched, according to a report
- Finimize — BASF Floats A Deal For Evonik In A Busy M&A Day
- WSJ — Chemicals Giant BASF Moves for Rival Evonik
- Seeking Alpha — Evonik gains after report of BASF takeover approach (update) (EVKIF:OTCMKTS)
- Yahoo Finance — BASF proposes takeover of German chemical rival Evonik, Financial Times reports
- ICIS — BASF confirms it is in talks to acquire German specialty firm Evonik
- Investing.com — M&A market trends: BASF/Evonik, arb spreads, and tokenization deals this week
- www.marketscreener.com — Chemicals Giant BASF Moves for Rival Evonik -- Update
- www.marketscreener.com — IG BCE: BASF takeover of Evonik need not make sense
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community